Please login to the form below
cervical cancer
This page shows the latest cervical cancer news and features for those working in and with pharma, biotech and healthcare.
Pfizer to acquire Seagen for $43bn in biggest pharma transaction since 2019
Pfizer's oncology portfolio currently includes 24 approved drugs, while Seagen's includes Adcetris for lymphomas, Padcev for bladder cancers, Tivdak for cervical cancer, and Tukysa for breast and colorectal cancers. ... Unlike chemotherapy, which works
Latest news
-
MSD’s Keytruda plus chemotherapy approved in Scotland for advanced cervical cancer
There were around 604, 000 new cases and 342, 000 deaths in 2020 from cervical cancer. ... There are more diagnoses of advanced cervical cancer in areas of high deprivation and among people of working age.
-
World Health Organization releases new road map for breast cancer
Nearly 80% of breast and cervical cancer deaths occur in low- and middle-income countries. ... Since 2018, WHO has developed integrated initiatives in women’s and children’s cancers, also calling for the elimination of cervical cancer and a doubling
-
EC launches cancer imaging initiative to accelerate innovation and early diagnosis
As part of the plan’s prevention goals, the EC is aiming to offer access to breast, cervical and colorectal cancer screening to 90% of eligible Europeans. ... The European Cancer Imaging Initiative we launch today will play a major role in this.”.
-
Regeneron’s Libtayo granted EC approval for recurrent or metastatic cervical cancer
Approximately 600, 000 new cases of cervical cancer and 350, 000 deaths from cervical cancer occur worldwide each year. ... Cervical cancer is often curable when detected early and effectively managed, but treatment options are more limited in advanced
-
Roche announces launch of HPV self-sampling solution for cervical cancer screening
Around 342, 000 die from cervical cancer worldwide, despite it being a preventable disease. ... Underdeveloped nations carry the highest burden of cervical cancer, but access to adequate treatment can be challenging.
More from news
Approximately 16 fully matching, plus 158 partially matching documents found.
Latest Intelligence
-
World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
The result? 70% of all cancer deaths in 2020 were in low- and middle-income countries. ... In the US for example, five-year survival for cervical cancer is lower in black women (58%) than it is in white women (71%), while people living in segregated
-
Why digital is the solution to the healthcare crisis
Be it treatment for cancer, aches and pains, unusual lumps, headaches – the general malay that you would visit your doctor or hospital for consultation and treatment. ... For example, the Irish Times recently reported that nearly 90% of women have not
-
Surviving cancer: a new era for patients
This treatment quickly became the ‘gold standard’ for women with metastatic breast cancer. ... a terminal disease, and more towards helping cancer patients manage their condition effectively.
-
2019: CRISPR and therapeutic gene editing comes of age
hope was that - without the brake of PD-1 – the edited cells would attack and defeat the cancer. ... The approach is however also set to be tested as an in vivo therapy for cervical cancer caused by human papillomavirus (HPV) by researchers in China,
-
AI’s potential in the pharma life cycle
Proactive intervention. Already AI is being used to identify women whose Twitter posts indicate they may have increased risk of developing two relatively rare diseases: ovarian cancer and cervical cancer.
More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.
Latest appointments
-
Merck appoints new senior vice president
Radvanyi will focus on leading the discovery of oncology therapies that leverage the natural ability of the body's immune system to fight cancer, as well as identifying biomarkers with the ... indications including lung, cervical and breast cancer.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Could femtech be the answer to the gender health gap?
They are even working with the WHO, helping them towards their goal of eliminating cervical cancer – their first ever plan to eliminate a cancer! ... Accessed November 3, 2021. World Health Organisation. A cervical cancer-free future: First-ever global
-
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality &Diversity committee will be looking at raising awareness around Cervical Cancer. ... Cervical cancer remains a threatening disease for many women, in fact every year in the UK, as many as 3, 200
-
Women’s 2021 health wins worth celebrating
A study finding that cervical cancer rates are almost 90% lower in women who have been vaccinated against HPV.
-
Innovative Trials
Cervical Cancer Prevention Month. ... In this first 2022 blog, the Innovative Trials' Equality &Diversity committee will be looking at raising awareness around Cervical Cancer.
-
'Smear Word' campaign for Roche aims to break taboos and save lives
Many young women do not turn up for appointments, which puts them at risk of early signs of cervical cancer being missed. ... your life – with cervical cancer highly preventable through regular screening and vaccination.
More from PMHub
Approximately 2 fully matching, plus 11 partially matching documents found.
Subscribe to our email news alerts
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- FDA external report recommends actions to address US opioid crisis
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- The increasing value of rare disease trials
- Wrapping up EAU with a Look at Medscape’s Urology Impact
- MHRA to introduce new UK clinical trials framework
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate
- Congress is in session – how companies are boosting their impact and engagement
- AstraZeneca announces major expansion of Canadian research footprint
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
PMHub
Healthcare Media Europe – HME Ltd
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
